zeneca's direct to consumer advertising of nolvadex center for social innovation csi skip to content center for social innovation csi center for social innovation az index find people visit admissions faculty & research alumni recruiters & companies news about the gsb search csi search the gsb home research by topic healthcare zeneca's direct to consumer advertising of nolvadex home research by topic arts culture and religion corporate social responsibility economic development education environment government leadership healthcare human rights nonprofit management philanthropy responsible investing social entrepreneurship student programs executive programs gsb social innovators community engagement events about csi more content blog social innovation podcast e newsletter videos follow us icon face book icon twitter zeneca's direct to consumer advertising of nolvadex academic case study by margaret l eaton naveen chopra published 2005 topics healthcare tweet in may 1999 the moon shot team gathered to review the results of a $54.4 million direct to consumer dtc ad campaign moon shot was a cross functional team at zeneca inc a pharmaceutical agrochemical and specialty products company the ad campaign was to promote the use of the drug nolvadex zeneca's brand name for tamoxifen citrate for use in reducing the risk of breast cancer in women at high risk an estimated nine million women in the united states this case details zeneca's development of tamoxifen and how the company marketed the drug the case focuses zeneca's direct to consumer dtc prescription drug advertising campaign and the issues raised by that campaign gsb faculty students and staff only may view pdf document authorization required case no bme2 admissions faculty & research alumni recruiters & companies giving executive education news about the gsb copyright 2009 stanford graduate school of business site help terms of use & policies stanford university
